According to Citius Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$5.50. a decrease over its 2023 EPS that were of -$5.57.
Year | EPS | Change |
---|---|---|
2024 | -$5.97 | 7.18% |
2023 | -$5.57 | -3.13% |
2022 | -$5.75 | -0% |
2021 | -$5.75 | -48.89% |
2020 | -$11.25 | -41.56% |
2019 | -$19.25 | -34.19% |
2018 | -$29.25 | -38.1% |
2017 | -$47.25 | -17.47% |
2016 | -$57.25 | 67.15% |
2015 | -$34.25 | |
2014 | N/A | -100% |
2013 | -$1.05 | 42.55% |
2012 | -$0.73 | |
2011 | N/A |